Literature DB >> 2154330

Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.

P M Pour1, K Kazakoff, K Carlson.   

Abstract

The effects of streptozotocin (SZ) and N-nitrosobis(2-oxopropyl)amine (BOP), separately or in combination, on the pancreas, common duct, and gallbladder, all target tissues of BOP, were studied in Syrian golden hamsters. Groups of hamsters were treated with either a single dose (20 mg/kg body weight) of BOP (BOP group), or a single i.p. dose (50 mg/kg body weight) of SZ and 14 days later with a single s.c. injection of the same dose of BOP (SZ + BOP group). Another group of animals was treated similarly with BOP and SZ except that they received twice daily injections of insulin, beginning 1 day after SZ administration and for the duration of the experiment (52 weeks) (SZ + insulin + BOP group). The control group consisted of hamsters treated with a single dose of BOP and daily doses of insulin (insulin + BOP group). Hamsters treated with SZ recovered spontaneously from their diabetes, although the mortality was high (86%). BOP treatment inhibited the diabetogenic effects of SZ in both SZ + BOP and SZ + insulin + BOP groups and reduced the mortality to 43 and 74%, respectively. SZ pretreatment inhibited the incidence of BOP-induced pancreatic ductal/ductular cell carcinomas in the SZ + BOP group (P less than 0.01); this protective effect of SZ on carcinoma development was potentiated by additional treatment with insulin (SZ + insulin + BOP group, P less than 0.001). Although the frequency of BOP-induced tumors in the gallbladder (all polyps) was not altered by either SZ or insulin, the frequency of the common duct polyps was significantly lower in the SZ + insulin + BOP group than in the BOP group (P less than 0.005). Hamsters in the SZ, SZ + BOP, and SZ + insulin + BOP groups developed islet cell adenomas (insulomas). However, the SZ + insulin + BOP group had significantly fewer insulomas than in the SZ + BOP group (P less than 0.0005). The overall data confirm the inhibitory effect of SZ on BOP-induced pancreatic cancer and suggest that this effect is related to the diabetic condition of hamsters rather than insulin deficiency and that intact islets appear to be prerequisite for exocrine pancreatic cancer induction by BOP. On the other hand, the inhibitory action of insulin on insuloma induction by SZ and on ductal/ductular cancer induction by BOP seems to be related to the suppressive effect of this hormone on beta-cell and ductal/ductular cell replication, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154330

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Submandibular gland as a site for islet transplantation.

Authors:  P M Pour; L G Weide; K Ueno; S Corra; K Kazakoff
Journal:  Int J Pancreatol       Date:  1992-10

2.  One thousand faces of Langerhans islets.

Authors:  P M Pour; B M Schmied
Journal:  Int J Pancreatol       Date:  1999-06

Review 3.  The role of Langerhans islets in exocrine pancreatic cancer.

Authors:  P M Pour
Journal:  Int J Pancreatol       Date:  1995-06

4.  The patterns of beta-cell regeneration in untreated diabetic and insulin-treated diabetic Syrian hamsters after streptozotocin treatment.

Authors:  T Tomioka; H Fujii; M Hirota; K Ueno; P M Pour
Journal:  Int J Pancreatol       Date:  1991-05

5.  Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans.

Authors:  P M Pour; L Weide; G Liu; K Kazakoff; M Scheetz; I Toshkov; Y Ikematsu; M A Fienhold; W Sanger
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 6.  The link between exocrine pancreatic cancer and the endocrine pancreas.

Authors:  P M Pour; B Schmied
Journal:  Int J Pancreatol       Date:  1999-04

7.  Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model.

Authors:  P M Pour; K Kazakoff
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

8.  Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.

Authors:  Rachael Z Stolzenberg-Solomon; Catherine Schairer; Steve Moore; Albert Hollenbeck; Debra T Silverman
Journal:  Am J Clin Nutr       Date:  2013-08-28       Impact factor: 7.045

Review 9.  Vitamin D and pancreatic cancer.

Authors:  Rachael Z Stolzenberg-Solomon
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

10.  Beta cell transdifferentiation does not contribute to preneoplastic/metaplastic ductal lesions of the pancreas by genetic lineage tracing in vivo.

Authors:  Oliver Strobel; Yuval Dor; Amy Stirman; Amanda Trainor; Carlos Fernández-del Castillo; Andrew L Warshaw; Sarah P Thayer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.